Evidence map›Paper›PMID 34166143›Full record

ArticleJournal of attention disorders2022

Exploring ADHD Symptoms and Associated Impairment across Development.

Ayako Niina, Olga Eyre, Robyn Wootton, Evie Stergiakouli, Anita Thapar, Lucy Riglin

Abstract read
In one paragraph

Article in Journal of attention disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ayako NiinaDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK.ORCID 0000-0002-6577-7908
Olga EyreDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK.
Robyn WoottonMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Evie StergiakouliMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Anita ThaparDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK.
Lucy RiglinDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK.

Funding

Medical Research Council G9815508Medical Research Council MC_PC_15018Medical Research Council MC_PC_19009Medical Research Council MC_UU_00011/1Medical Research Council MC_UU_00011/3Wellcome Trust 204895Wellcome Trust 204895/Z/16/ZWellcome Trust 217065/Z/19/Z
6 · The paper itself

Abstract

objectiveADHD symptoms typically decline with age, but less is known about whether the presentation of specific ADHD symptoms differs across development. This study aimed to examine the frequency and associated impairment of specific ADHD symptoms in childhood, adolescence, and young adulthood.

methodA prospective, longitudinal cohort, the Avon Longitudinal Study of Parents and Children, was utilized (

resultsSpecific ADHD symptom frequencies and their associated impairment varied across development for the majority of symptoms, although

conclusionThese findings suggest differences in the presentations of ADHD symptoms across development: current understanding of how ADHD presents in childhood/adolescence may not be generalizable to young adulthood.

Indexed as

Attention Deficit Disorder with HyperactivityAdolescentAdultChildCohort StudiesHumansLongitudinal StudiesParentsProspective StudiesYoung AdultADHDadultALSPACimpairmentlongitudinalprospective

Identifiers

PMID34166143
PMCPMC7612406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.